MIM
SRDX

Macroview Investment Management’s Surmodics SRDX Stock Holding History

Macroview Investment Management’s Portfolio SRDX Stock Details SRDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-57
Closed -$2K – 364
2019
Q1 		$2K Buy
57
+5
+10% +$255 0.01% 305
2018
Q4 		$2K Buy
+52
New +$3.12K 0.01% 289

Other funds holding SRDX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
TI
Trigran Investments Northbrook, Illinois $545M AUM 56.2% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Macroview Investment Management's SRDX Position: Q2 2019 in Review

Macroview Investment Management sold out of Surmodics (SRDX) in Q2 2019, closing a stake of 57 shares — an estimated $2K sold.

Macroview Investment Management first reported a position in SRDX in Q4 2018 and held it in 2 quarters. The position peaked at $2K in Q1 2019. 140 funds tracked by Wall St. Rank hold SRDX as of Q2 2019.

  • Macroview Investment Management reported no remaining Surmodics position as of Q2 2019 after selling out during the quarter.
  • Macroview Investment Management sold 57 Surmodics shares in Q2 2019, an estimated $2K.
  • Macroview Investment Management first reported a position in Surmodics in Q4 2018 and held it in 2 quarters.
  • Macroview Investment Management's Surmodics position peaked at $2K in Q1 2019.
  • 140 funds tracked by Wall St. Rank held Surmodics as of Q2 2019.

Based on Macroview Investment Management's 13F filing for Q2 2019, filed 23 Jul 2019.